Publikationen von Heinrich Schrewe

Eijken, M.; Krautzberger, A. M.; Scholze-Wittler, M.; Boers-Sijmons, B.; Koedam, M.; Kosiol, B.; Schrewe, H.; van Leeuwen, J. P.; van der Eerden, B. C.: Vasorin-deficient mice display disturbed vitamin D and mineral homeostasis in combination with a low bone mass phenotype. Bone Reports 22, Article 101792 (2024)

Andrique, C.; Bonnet, A. L.; Dang, J.; Lesieur, J.; Krautzberger, A. M.; Baroukh, B.; Torrens, C.; Sadoine, J.; Schmitt, A.; Rochefort, G. Y. et al.; Bardet, C.; Six, I.; Houillier, P.; Tharaux, P. L.; Schrewe, H.; Gaucher, C.; Chaussain, C.: Vasorin as an actor of bone turnover? Journal of Cellular Physiology 239 (6), Article e31257 (2024)

Louvet, L.; Lenglet, G.; Krautzberger, A. M.; Mentaverri, R.; Hague, F.; Kowalewski, C.; Mahtal, N.; Lesieur, J.; Bonnet, A.-L.; Andrique, C. et al.; Gaucher, C.; Gomila, C.; Schrewe, H.; Tharaux, P.-L.; Kamel, S.; Chaussain, C.; Six, I.: Vasorin plays a critical role in vascular smooth muscle cells and arterial functions. Journal of Cellular Physiology 237 (10), S. 3845 - 3859 (2022)

Huang, T.-W.; Iyer, A. A.; Manalo, J. M.; Woo, J.; Bosquez Huerta, N. A.; McGovern, M. M.; Schrewe, H.; Pereira, F. A.; Groves, A. K.; Ohlemiller, K. K. et al.; Deneen, B.: Glial-Specific Deletion of Med12 Results in Rapid Hearing Loss via Degradation of the Stria Vascularis. The Journal of Neuroscience 41 (34), S. 7171 - 7181 (2021)

Segal, J.; Mülleder, M.; Krüger, A.; Adler, T.; Scholze-Wittler, M.; Becker, L.; Calzada-Wack, J.; Garrett, L.; Hölter, S. M.; Rathkolb, B. et al.; Rozman, J.; Racz, I.; Fischer, R.; Busch, D. H.; Neff, F.; Klingenspor, M.; Klopstock, T.; Grüning, N.-M.; Michel, S.; Lukaszewska-McGreal, B.; Voigt, I.; Hartmann, L.; Timmermann, B.; Lehrach, H.; Wolf, E.; Wurst, W.; Gailus-Durner, V.; Fuchs, H.; de Angelis, M. H.; Schrewe, H.; Yuneva, M.; Ralser, M.: Low catalytic activity is insufficient to induce disease pathology in triosephosphate isomerase (TPI) deficiency. Journal of Inherited Metabolic Disease 22 (5), S. 839 - 849 (2019)

Baskin, K. K.; Makarewich, C. A.; DeLeon, S. M.; Ye, W.; Chen, B.; Beetz, N.; Schrewe, H.; Bassel-Duby, R.; Olson, E. N.: MED12 regulates a transcriptional network of calcium-handling genes in the heart. JCI Insight 2 (14), e91920 (2017)

Vermeren, M. M.; Zhang, Q.; Smethurst, E.; Segonds-Pichon, A.; Schrewe, H.; Wakelam, M. J. O.: The Phospholipase D2 Knock Out Mouse Has Ectopic Purkinje Cells and Suffers from Early Adult-Onset Anosmia. PLoS One 11 (9), e0162814 (2016)

Milenkovic, A.; Brandl, C.; Milenkovic, V. M.; Jendryke, T.; Sirianant, L.; Wanitchakool, P.; Zimmermann, S.; Reiff, C. M.; Horling, F.; Schrewe, H. et al.; Schreiber, R.; Kunzelmann, K.; Wetzel, C. H.; Weber, B. H. F.: Bestrophin 1 is indispensable for volume regulation in human retinal pigment epithelium cells. Proceedings of the National Academy of Sciences of the United States of America 112 (20), S. E2630 - E2639 (2015)

Vucicevic, D.; Schrewe, H.; Ørom, U. A.: Molecular mechanisms of long ncRNAs in neurological disorders. Frontiers in Genetics 5, 5:48 (2014)

Vogl, M. R.; Reiprich, S.; Küspert, M.; Kosian, T.; Schrewe, H.; Nave, K.-A.; Wegner, M.: Sox10 cooperates with the mediator subunit 12 during terminal differentiation of myelinating glia. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience 33 (15), S. 6679 - 6690 (2013)

Kämpjärvi, K.; Mäkinen, N.; Kilpivaara, O.; Arola, J.; Heinonen, H.-R.; Böhm, J.; Abdel-Wahab, O.; Lehtonen, H. J.; Pelttari, L. M.; Mehine, M. et al.; Schrewe, H.; Nevanlinna, H.; Levine, R. L.; Hokland, P.; Böhling, T.; Mecklin, J.-P.; Bützow, R.; Aaltonen, L. A.; Vahteristo, P.: Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer. British Journal of Cancer 107, S. 1761 - 1765 (2012)

Krautzberger, M. K.; Kosiol, B.; Scholze, M.; Schrewe, H.: Expression of vasorin (Vasn) during embryonic development of the mouse. Gene Expression Patterns 12 (5-6), S. 167 - 171 (2012)

Kammerer, R.; Rüttiger, L.; Riesenberg, R.; Schäuble, C.; Krupar, R.; Kamp, A.; Sunami, K.; Eisenried, A.; Hennenberg, M.; Grunert, F. et al.; Breß, A.; Battaglia, S.; Schrewe, H.; Knipper, M.; Schneider, M. R.: Loss of the mammal-specific tectorial membrane component CEA cell adhesion molecule 16 (CEACAM16) leads to hearing impairment at low and high frequencies. Journal of Biological Chemistry 287, S. 21584 - 21598 (2012)

Schwaerzer, G. K.; Hiepen, C.; Schrewe, H.; Nickel, J.; Ploeger, F.; Sebald, W.; Mueller, T.; Knaus, P.: New insights into the molecular mechanism of multiple synostoses syndrome (SYNS): mutation within the GDF5 knuckle epitope causes noggin-resistance. Journal of Bone and Mineral Research 27 (2), S. 429 - 442 (2012)

Norton, L. J.; Zhang, Q.; Saqib, K. M.; Schrewe, H.; Macura, K.; Anderson, K. E.; Lindsley, C. W.; Brown, H. A.; Rudge, S. A.; Wakelam, M. J.: PLD1 rather than PLD2 regulates phorbol-ester-, adhesion-dependent and Fc{gamma}-receptor-stimulated ROS production in neutrophils. J Cell Sci 124 (Pt 12), S. 1973 - 1983 (2011)

Althoff, G. E. M.; Wolfer, D. P.; Timmesfeld, N.; Kanzler, B.; Schrewe, H.; Axel, P.: Long-Term Expression of Tissue-Inhibitor of Matrix Metalloproteinase-1 in the Murine Central Nervous System Does Not Alter the Morphological and Behavioral Phenotype but Alleviates the Course of Experimental Allergic Encephalomyelitis. The American Journal of Pathology 177 (2), S. 840 - 853 (2010)

Rocha, P. P.; Scholze, M.; Bleiß, W.; Schrewe, H.: Med12 is essential for early mouse development and for canonical Wnt and Wnt/PCP signaling. Development 137, S. 2723 - 2731 (2010)

Rocha, P. P.; Bleiss, W.; Schrewe, H.: Mosaic Expression of Med12 in Female Mice Leads to Exencephaly, Spina Bifida, and Craniorachischisis. Birth Defects Research Part A: Clinical and Molecular Teratology 88 (8), S. 626 - 632 (2010)

Khanim, F. L.; Hayden, R. E.; Birtwistle, J.; Lodi, A.; Tiziani, S.; Davies, N. J.; Ride, J. P.; Viant, M. R.; Gunther, U. L.; Mountford, J. C. et al.; Schrewe, H.; Green, R. M.; Murray, J. A.; Drayson, M. T.; Chris, M. B.: Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia. PLoS ONE 4 (12), S. e8147 - e8147 (2009)

Birtwistle, J.; Hayden, R. E.; Khanim, F. L.; Green, R. M.; Pearce, C.; Davies, N. J.; Wake, N.; Schrewe, H.; Ride, J. P.; Chipman, J. K. et al.; Bunce, C. M.: The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: Implications for leukemogenesis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 662 (1-2), S. 67 - 74 (2009)